Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New parental cell lines for generating human hybridomas.

T Hundhausen1, R Laus, W Müller-Ruchholtz

  • 1Department of Immunology, University of Kiel, Germany.

Journal of Immunological Methods
|August 30, 1992
PubMed
Summary

Creating human hybridomas is challenging due to a lack of suitable cell lines. This study establishes HGPRT/TK-deficient human parent cell lines, enabling efficient human hybridoma production for T lymphocyte research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of coal mining waste for the removal of acidity and metal ions Al (III), Fe (III) and Mn (II) in acid mine drainage.

Environmental technology·2008
Same author

Evaluation of remediation of coal mining wastewater by chitosan microspheres using biomarkers.

Archives of environmental contamination and toxicology·2006
Same author

False-positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new-generation plastic bottles: a multicenter pilot study.

Transfusion·2005
Same author

Use of chitosan microspheres as remedial material for acidity and iron (III) contents of coal mining wastewaters.

Environmental technology·2004
Same author

Major histocompatibility complex class I-restricted presentation of protein antigens without prior intracellular processing.

Scandinavian journal of immunology·2003
Same author

RHCE-D-CE hybrid genes can cause false-negative DNA typing of the Rh e antigen.

Vox sanguinis·2002

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • Producing human hybridomas is difficult compared to mouse hybridomas, primarily due to the absence of suitable malignant human cell lines.
  • Hybridoma technology is crucial for monoclonal antibody production and studying cell function.

Purpose of the Study:

  • To establish human parent cell lines deficient in hypoxanthine guanosine phosphoribosyl transferase (HGPRT) and/or thymidine kinase (TK) for human hybridoma production.
  • To evaluate selection strategies and media for efficient isolation of true human hybridomas.
  • To explore the potential of these cell lines for generating human T-T hybridomas for T lymphocyte research.

Main Methods:

  • Engineered leukemic cell lines (REH, 1301, SKW-3) to be deficient in HGPRT and/or TK.

Related Experiment Videos

  • Developed and utilized novel selection media, including hypoxanthine/aminopterine/thymidine/azaserine (HATA) and azaserine/hypoxanthine (AH).
  • Assessed the efficiency of selection procedures for eliminating enzyme-deficient parent cells and isolating hybridomas.
  • Characterized generated human T-T hybridomas for karyotype and surface antigen expression.
  • Main Results:

    • Successfully established three human parent cell lines with specific enzyme deficiencies (HGPRT and/or TK).
    • Demonstrated that combined HGPRT and TK deficiencies, coupled with HATA medium, significantly improved hybridoma selection.
    • Identified the thymidine-free AH medium as having low nonspecific toxicity.
    • Showcased a subclone of the SKW-3 cell line's exceptional ability to generate stable, nearly tetraploid human T-T hybridomas expressing new surface antigens.

    Conclusions:

    • The developed HGPRT/TK-deficient human cell lines and selection strategies overcome previous limitations in human hybridoma production.
    • The new hybridoma technology provides a powerful tool for investigating human T lymphocyte function.
    • This advancement opens new avenues for research in immunology and related fields.